Background Image
Table of Contents Table of Contents
Previous Page  10 / 74 Next Page
Information
Show Menu
Previous Page 10 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 6, November/December 2018

342

AFRICA

Electrocardiographic criteria signifying left ventricular

hypertrophy and reduction of cardiothoracic index were most

notably seen in patients who received nos 21, 23 and 25

mechanical valves. By contrast, the least remarkable improvement

was observed in cases operated on with no 19 mechanical valves

(Table 3).

Discussion

This study was performed to compare the functional and

anatomical changes in patients who underwent AVR with

different-sized mechanical valves. Our results demonstrated

that improvements and anatomical changes were observed most

notably in patients that received nos 21, 23 and 25 valves.

Aortic stenosis causes left ventricular hypertrophy as an

adaptive response to increasing pressure. Persistence of this load

may impede myocardial contractility and pump function. Aortic

valve replacement may relieve the pressure overload and result

in reversal of anatomical and functional changes due to aortic

stenosis. These improvements can be linked to factors such as the

timing of surgery, type and size of the mechanical prosthesis, and

valvular pathology.

12

However, complete regression of myocardial

hypertrophy may not occur since the hypertrophic myocytes

may have undergone irreversible changes.

13

Our results indicate

that patients with higher residual gradients and increased left

ventricular end-diastolic pressures experienced a less remarkable

decrease in left ventricular mass.

Irreversible myocardial depression and fibrosis, which

develops as a consequence of long-term aortic stenosis must be

borne in mind before deciding on surgery. Symptomatic patients

who suffer from angina pectoris, dyspnoea or syncope benefit

more significantly from AVR and have prolonged survival after

surgery.

14

Even for asymptomatic patients, the risk of sudden

death and irreversible left ventricular dysfunction may be

prevented with surgery.

15

Type and size of the prosthetic valve as well as other peri-

operative factors may influence anatomical and functional

changes after AVR. De Paulis

et al

. reported a significant

reduction in LVM in patients operated on due to aortic stenosis.

16

Bioprostheses without stents and aortic allografts are expected

to provide a more remarkable reduction in LVH and left

ventricular function.

16

Maselli

et al

. suggested that residual gradient and

high pressure in the left ventricle were responsible for the

unsatisfactory reduction in left ventricular mass after AVR.

17

In the same study, homograft valves yielded more significant

reductions in LVMI.

17

In contrast to these reports, Christakis

et

al

. could not demonstrate any impact of the type of prosthesis

on regression of LVM.

18

Prosthetic valves without stents

provided optimal regression on LVM within one year of the

operation.

19

A better haemodynamic performance was achieved using

prostheses without stents than with bioprostheses and stents.

18

Gonzalez-Juanatey

et al

. reported that larger prostheses

resulted in a more apparent reduction in LVH.

20

Similar to

this study, our results indicate that most significant changes in

LVM occurred in the sixth month postoperatively. Variations

in the amount of regression in LVM in our patients receiving

nos 19, 21, 23 and 25 prostheses were 25, 26.7, 27.8 and 30.2%,

respectively.

Botzenhardt

et al

. demonstrated mean pressure gradients

of 11.5

±

3.8 mmHg for no 21 and 12.7

±

5.0 mmHg for no 25

valves.

21

However, they realised that haemodynamic performance

was not primarily influenced by valve size but more by sizing

strategy, and therefore the selection of a given valve size

according to the patient’s anatomy. Since the relationship would

be similar for all valve sizes, it was not surprising to observe

similar pressure gradients with different valve sizes.

A residual gradient after AVR may cause persistence of LVH

and lead to increased mortality rates in the late period.

22

Lund

et al

. postulated that LVMI was closely associated with survival

after AVR.

23

If the effective surface area of the prosthesis is less

than a normal valve, a mismatch between patient and prosthesis

occurs, and this may be an important determinant of residual

gradient and persistent LVH.

24

The role of the surgeon and the sizing strategy adopted

appear to be very important in exploiting or failing to exploit the

haemodynamic characteristics of the prosthesis.

25

For selection

of the appropriate valve size, most authors advocate the use

of valves larger than no 21.

26

Smaller valves may lead to a high

transvalvular gradient, even at rest. Selecting a larger valve

bears a greater risk of causing damage, specifically to the aorta

around the aortotomy. When selecting a larger prosthesis, it may

be necessary to take the valve off the holder and tilt it for proper

introduction into the root.

27,28

We determined that patients who received no 19 valves

experienced less regression of LVM, especially in the third

and fifth postoperative years. In all groups, changes were more

obvious in the sixth postoperative month, whereas these changes

became less notable after the first year.

Regression of LVMmostly happens in the early postoperative

period after AVR, and persistence of LVH and deterioration of

left ventricular diastolic function may be one of the underlying

causes of sudden death. Our findings revealed that all groups

displayed a significant improvement in ejection fraction in the

sixth postoperative month. However, changes were more obvious

in cases that received nos 23 and 25 prosthetic valves.

Cardiac hypertrophy on ECG displays a correlation between

voltage criteria and LVMI.

29,30

In parallel to our results mentioned

above, voltage criteria exhibited the most prominent changes

with valve nos 23 and 25, and the least change occurred in

patients receiving no 19 valves.

The amount of regression of LVM after AVR is related to

degenerative changes in the myocardium and decrease in left

ventricular reserve. These factors must be kept in mind before

deciding on surgical intervention for aortic stenosis. Moreover,

in addition to size and type of prosthesis, the aetiology of aortic

stenosis and timing of surgery must be considered.

The main limitation of our study was the distribution of

patients in the study groups. The four patient groups were

determined by the different valve sizes, and almost 80% of the

patients were in the two groups with valve sizes nos 21 and 23.

Conclusion

The results of this study indicate that mechanical valve replacement

should not be performed with small size valves because of the

higher residual gradient. Instead, mechanical valve replacement

with larger sized valves, together with aortic root enlargement

procedures appears to be a more appropriate option.